A case of discordant histology and expression of programmed death ligand 1 between primary tumor and brain metastases in adenosquamous carcinoma of the lung

por Takagi, Hironori, Muto, Satoshi, Enta, Akio, Fukuhara, Mitsuro, Asano, Shigeyuki, Shio, Yutaka, Suzuki, Hiroyuki
Publicado 2023

Successful Treatment of Combined Large Cell Neuroendocrine Carcinoma Harboring an EGFR Mutation with EGFR-TKIs plus Bevacizumab: A Case Report

por Muto, Satoshi, Ozaki, Yuki, Okabe, Naoyuki, Matsumura, Yuki, Hasegawa, Takeo, Shio, Yutaka, Hashimoto, Yuko, Suzuki, Hiroyuki
Publicado 2020

Diffuse Cystic Metastases in the Lung after Nivolumab Treatment in a Patient with Non-Small Cell Lung Cancer: A Case Report

por Muto, Satoshi, Ozaki, Yuki, Inoue, Takuya, Okabe, Naoyuki, Matsumura, Yuki, Hasegawa, Takeo, Shio, Yutaka, Suzuki, Hiroyuki
Publicado 2021

Pulmonary large cell carcinoma, highly positive for PD‐L1, shows marked response to pembrolizumab: A case report

por Okabe, Naoyuki, Mine, Hayato, Takagi, Hironori, Watanabe, Masayuki, Muto, Satoshi, Matsumura, Yuki, Shio, Yutaka, Suzuki, Hiroyuki
Publicado 2021

Successful Management of Crizotinib-Induced Neutropenia in a Patient with Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer: A Case Report

por Osugi, Jun, Owada, Yuki, Yamaura, Takumi, Muto, Satoshi, Okabe, Naoyuki, Matsumura, Yuki, Higuchi, Mitsunori, Suzuki, Hiroyuki, Gotoh, Mitsukazu
Publicado 2016

Our experience of lung resection in patients who decline blood transfusion for religious reasons

por Takagi, Hironori, Muto, Satoshi, Yamaguchi, Hikaru, Mine, Hayato, Ozaki, Yuki, Okabe, Naoyuki, Matsumura, Yuki, Shio, Yutaka, Suzuki, Hiroyuki
Publicado 2021

Characteristics and overall survival of EGFR mutation-positive non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors: a retrospective analysis for 1660 Japanese p...

por Inoue, Akira, Yoshida, Kazushi, Morita, Satoshi, Imamura, Fumio, Seto, Takashi, Okamoto, Isamu, Nakagawa, Kazuhiko, Yamamoto, Nobuyuki, Muto, Satoshi, Fukuoka, Masahiro
Publicado 2016

Thoracoscopic resection of posterior mediastinal paraganglioma: perioperative management and surgical tips

por Matsumura, Yuki, Fukuhara, Mitsuro, Tanabe, Hayato, Yamaguchi, Hikaru, Takagi, Hironori, Ozaki, Yuki, Muto, Satoshi, Okabe, Naoyuki, Shio, Yutaka, Suzuki, Hiroyuki
Publicado 2022

Lung adenocarcinoma coexisting with diffuse idiopathic pulmonary neuroendocrine cell hyperplasia manifesting as multiple pulmonary nodules: A case report

por Inomata, Sho, Matsumura, Yuki, Kobayashi, Yasuyuki, Yamaguchi, Hikaru, Watanabe, Masayuki, Ozaki, Yuki, Muto, Satoshi, Okabe, Naoyuki, Shio, Yutaka, Suzuki, Hiroyuki
Publicado 2022

Nivolumab-related severe thrombocytopenia in a patient with relapsed lung adenocarcinoma: a case report and review of the literature

por Hasegawa, Takeo, Ozaki, Yuki, Inoue, Takuya, Watanabe, Yuzuru, Fukuhara, Mitsuro, Yamaura, Takumi, Muto, Satoshi, Okabe, Naoyuki, Higuchi, Mitsunori, Shio, Yutaka, Suzuki, Hiroyuki
Publicado 2019

Large cell neuroendocrine carcinoma of the lung controlled for 4 years by a single administration of pembrolizumab: A case report

por Watanabe, Masayuki, Matsumura, Yuki, Yamaguchi, Hikaru, Mine, Hayato, Takagi, Hironori, Ozaki, Yuki, Fukuhara, Mitsuro, Muto, Satoshi, Okabe, Naoyuki, Shio, Yutaka, Suzuki, Hiroyuki
Publicado 2022

Clinical significance of expanded Foxp3(+) Helios(−) regulatory T cells in patients with non-small cell lung cancer

por MUTO, SATOSHI, OWADA, YUKI, INOUE, TAKUYA, WATANABE, YUZURU, YAMAURA, TAKUMI, FUKUHARA, MITSURO, OKABE, NAOYUKI, MATSUMURA, YUKI, HASEGAWA, TAKEO, OSUGI, JUN, HOSHINO, MIKA, HIGUCHI, MITSUNORI, SUZUKI, HIROYUKI, GOTOH, MITSUKAZU
Publicado 2015

An In Vitro System for Evaluating Molecular Targeted Drugs Using Lung Patient-Derived Tumor Organoids

por Takahashi, Nobuhiko, Hoshi, Hirotaka, Higa, Arisa, Hiyama, Gen, Tamura, Hirosumi, Ogawa, Mayu, Takagi, Kosuke, Goda, Kazuhito, Okabe, Naoyuki, Muto, Satoshi, Suzuki, Hiroyuki, Shimomura, Kenju, Watanabe, Shinya, Takagi, Motoki
Publicado 2019

A patient with ALK‐positive lung adenocarcinoma who survived alectinib‐refractory postoperative recurrence for 4 years by switching to ceritinib

por Matsumura, Yuki, Inomata, Sho, Yamaguchi, Hikaru, Mine, Hayato, Takagi, Hironori, Watanabe, Masayuki, Ozaki, Yuki, Yamaura, Takumi, Fukuhara, Mitsuro, Muto, Satoshi, Okabe, Naoyuki, Hasegawa, Takeo, Shio, Yutaka, Suzuki, Hiroyuki
Publicado 2021

Ectopic adrenocorticotropic hormone‐secreting carcinoid with solitary cryptococcosis in the lungs

por Takagi, Hironori, Matsumura, Yuki, Fukuhara, Mitsuro, Inomata, Sho, Yamaguchi, Hikaru, Watanabe, Masayuki, Ozaki, Yuki, Muto, Satoshi, Okabe, Naoyuki, Shio, Yutaka, Saito, Haruka, Tanabe, Hayato, Shimabukuro, Michio, Suzuki, Hiroyuki
Publicado 2022

FAM83B is a novel biomarker for diagnosis and prognosis of lung squamous cell carcinoma

por OKABE, NAOYUKI, EZAKI, JUNJI, YAMAURA, TAKUMI, MUTO, SATOSHI, OSUGI, JUN, TAMURA, HIROSUMI, IMAI, JUN-ICHI, ITO, EMI, YANAGISAWA, YUKA, HONMA, REIKO, GOTOH, MITSUKAZU, WATANABE, SHINYA, WAGURI, SATOSHI, SUZUKI, HIROYUKI
Publicado 2015

CLDN15 is a novel diagnostic marker for malignant pleural mesothelioma

por Watanabe, Masayuki, Higashi, Tomohito, Ozeki, Kana, Higashi, Atsuko Y., Sugimoto, Kotaro, Mine, Hayato, Takagi, Hironori, Ozaki, Yuki, Muto, Satoshi, Okabe, Naoyuki, Matsumura, Yuki, Hasegawa, Takeo, Shio, Yutaka, Suzuki, Hiroyuki, Chiba, Hideki
Publicado 2021

Construction of in vitro patient-derived tumor models to evaluate anticancer agents and cancer immunotherapy

por Takahashi, Nobuhiko, Higa, Arisa, Hiyama, Gen, Tamura, Hirosumi, Hoshi, Hirotaka, Dobashi, Yuu, Katahira, Kiyoaki, Ishihara, Hiroya, Takagi, Kosuke, Goda, Kazuhito, Okabe, Naoyuki, Muto, Satoshi, Suzuki, Hiroyuki, Shimomura, Kenju, Watanabe, Shinya, Takagi, Motoki
Publicado 2021

Myeloid-derived suppressor cells: Cancer, autoimmune diseases, and more

por Shibata, Masahiko, Nanno, Kotaro, Yoshimori, Daigo, Nakajima, Takahiro, Takada, Makoto, Yazawa, Takashi, Mimura, Kousaku, Inoue, Norio, Watanabe, Takafumi, Tachibana, Kazunoshin, Muto, Satoshi, Momma, Tomoyuki, Suzuki, Yoshiyuki, Kono, Koji, Endo, Shungo, Takenoshita, Seiichi
Publicado 2022

Prognostic Impact of Hypoxia-Inducible miRNA-210 in Patients with Lung Adenocarcinoma

por Osugi, Jun, Kimura, Yuka, Owada, Yuki, Inoue, Takuya, Watanabe, Yuzuru, Yamaura, Takumi, Fukuhara, Mitsuro, Muto, Satoshi, Okabe, Naoyuki, Matsumura, Yuki, Hasegawa, Takeo, Yonechi, Athushi, Hoshino, Mika, Higuchi, Mitsunori, Shio, Yutaka, Suzuki, Hiroyuki, Gotoh, Mitsukazu
Publicado 2015